These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 15474035

  • 1. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease.
    Boutajangout A, Boom A, Leroy K, Brion JP.
    FEBS Lett; 2004 Oct 08; 576(1-2):183-9. PubMed ID: 15474035
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT, Trojanowski JQ, Lee VM.
    Lab Invest; 1992 Feb 08; 66(2):212-22. PubMed ID: 1735956
    [Abstract] [Full Text] [Related]

  • 4. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M, Gaig C, Ascaso C, Muñoz E, Tolosa E.
    Brain Res; 2007 May 11; 1145():168-76. PubMed ID: 17320831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
    Togo T, Akiyama H, Iseki E, Uchikado H, Kondo H, Ikeda K, Tsuchiya K, de Silva R, Lees A, Kosaka K.
    Acta Neuropathol; 2004 Jun 11; 107(6):504-8. PubMed ID: 15024583
    [Abstract] [Full Text] [Related]

  • 7. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD, Ermak G, Davies KJ.
    FEBS J; 2007 Apr 11; 274(7):1715-24. PubMed ID: 17331188
    [Abstract] [Full Text] [Related]

  • 8. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT.
    Acta Neuropathol; 2007 Nov 11; 114(5):471-9. PubMed ID: 17721707
    [Abstract] [Full Text] [Related]

  • 9. Single molecule profiling of tau gene expression in Alzheimer's disease.
    Conrad C, Zhu J, Conrad C, Schoenfeld D, Fang Z, Ingelsson M, Stamm S, Church G, Hyman BT.
    J Neurochem; 2007 Nov 11; 103(3):1228-36. PubMed ID: 17727636
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM.
    Am J Pathol; 1993 Aug 11; 143(2):565-78. PubMed ID: 8342603
    [Abstract] [Full Text] [Related]

  • 12. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
    von Rotz RC, Kins S, Hipfel R, von der Kammer H, Nitsch RM.
    Eur J Neurosci; 2005 Mar 11; 21(5):1289-98. PubMed ID: 15813938
    [Abstract] [Full Text] [Related]

  • 13. Alternative splicing of amino-terminal Tau mRNA in rat spinal cord during development and following axonal injury.
    Halverson RA, Chambers CB, Muma NA.
    Exp Neurol; 2001 May 11; 169(1):105-13. PubMed ID: 11312563
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's disease.
    Hynd MR, Scott HL, Dodd PR.
    J Neurochem; 2004 Aug 11; 90(4):913-9. PubMed ID: 15287897
    [Abstract] [Full Text] [Related]

  • 15. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA, Nafe R, Schlote W.
    Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Haplotype-specific expression of exon 10 at the human MAPT locus.
    Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R.
    Hum Mol Genet; 2006 Dec 15; 15(24):3529-37. PubMed ID: 17085483
    [Abstract] [Full Text] [Related]

  • 19. Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology.
    Julien C, Tremblay C, Bendjelloul F, Phivilay A, Coulombe MA, Emond V, Calon F.
    J Neurosci Res; 2008 Aug 01; 86(10):2292-302. PubMed ID: 18338803
    [Abstract] [Full Text] [Related]

  • 20. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
    Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M.
    FEBS Lett; 2006 Jun 26; 580(15):3582-8. PubMed ID: 16753151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.